Income StatementOct '25Jul '25Apr '25Jan '25Oct '24Jul '24Apr '24Jan '24Oct '23Jul '23Apr '23Jan '23

Total Revenues

10,259

10,236

9,829

9,993

9,444

9,325

Total Revenues %Chg

8.6%

9.8%

7.6%

7.6%

8.3%

8.4%

Cost of Sales

2,255

2,242

2,265

2,217

2,105

2,159

Gross Profit

8,004

7,994

7,564

7,776

7,339

7,166

Gross Profit Margin

78%

78.1%

77%

77.8%

77.7%

76.8%

Selling, General & Administrative Expenses

4,123

4,177

4,126

4,238

4,034

3,935

Research & Development Expenses

1,433

1,481

1,460

1,420

1,356

1,349

Other Operating Expenses

260

4

36

298

56

99

Operating Profit

2,188

2,332

1,942

1,820

1,893

1,783

Operating Margin

21.3%

22.8%

19.8%

18.2%

20%

19.1%

Interest and Investment Income

—

—

—

—

—

—

Interest Expense

—

—

—

—

—

—

Non-Operating Income

324

74

32

168

-147

54

Total Non-Operating Income

324

74

32

168

-147

54

Income Before Provision for Income Taxes

2,512

2,406

1,974

1,988

1,746

1,837

Provision for Income Taxes

426

519

433

280

219

408

Consolidated Net Income

2,086

1,887

1,541

1,708

1,527

1,429

Net Income Attributable to Common Shareholders

2,086

1,887

1,541

1,708

1,527

1,429

Basic EPS

2.2

2

1.6

1.8

1.6

1.5

Diluted EPS

2.2

2

1.6

1.8

1.6

1.5

Basic Weighted Average Shares Outstanding

948

956

960

959

956

964

Total Shares Outstanding

952

955

958

962

956

958

Diluted Weighted Average Shares Outstanding

952

962

970

974

965

973

EBITDA

3,587

3,693

3,330

3,224

3,232

3,216

Effective Tax Rate

17%

21.6%

21.9%

14.1%

12.5%

22.2%